Table 3.
Drug Costs
| Drug Class | Observations | Mean US$ (95% CI) | Median US$ (IQR) |
|---|---|---|---|
| Nifedipine | 135 | 3.3 (3.0, 3.6) | 3.1 (1.8–4.4) |
| Hydrochlorothiazide | 45 | 2.9 (2.4, 3.4) | 2.6 (1.7–4.4) |
| Enalapril | 28 | 3.4 (2.7, 3.9) | 2.9 (1.9–4.5) |
| Atenolol | 17 | 3.1 (2.4, 3.8) | 2.6(1.8–4.7) |
| Nifedipine and hydrochlorothiazide | 28 | 3.6 (2.8, 4.4) | 2.9 (1.8–5.4) |
| Enalapril and nifedipine | 20 | 4.6 (3.6, 5.5) | 3.6 (2.9–5.7) |
| Enalapril and hydrochlorothiazide | 28 | 4.4 (3.3, 5.5) | 3.6 (2.6–5.1) |
| Atenolol and nifedipine | 12 | 5.2 (3.8, 6.5) | 5.1 (3.6–5.5) |
| Atenolol and hydrochlorothiazide | 5 | 5.7 (2.7, 8.7) | 5.8 (2.8–8.6) |
| Lasix and nifedipine | 5 | 4.6 (2.9, 6.3) | 4.7 (2.7–6.5) |
| Nifedipine/enalapril/lasix | 10 | 3.8 (3.1, 4.5) | 4.4 (2.5–4.7) |
| Othera | 16 | 3.7 (2.6, 4.8) | 3.3 (1.8–5.5) |
Notes: aLasix (n=2), methyldopa (n=1), metoclopramide (n=1), propranolol (n=1), atenolol and lasix (n=2), enalapril and atenolol (n=1), furosemide and nifedipine (n=2), furosemide and amlodipine (n=1), hydrochlorothiazide and amlodipine (n=1), hydrochlorothiazide and atorvastatin (n=1), hydropine and nifedipine (n=1), methyldopa and nifedipine (n=1), nifedipine and atrovestatinatorvastatin (n=1)
Abbreviations: US$, United States Dollar; CI, confidence interval; IQR, interquartile range.